Drugs / Coloverin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03147599 Comparator | May 2017 → May 2019 | nocturnal enuresis, urinary bladder cancer | Mansoura University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Coloverin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03147599 ↗ |
| Action | Inhibit | “It directly blocks voltage-operated sodium channels and inhibits intracellular calcium accumulation.” NCT03147599 ↗ |